Vireo Enters Pennsylvania in 11th-State License Deal

Vireo Growth is buying its way into Pennsylvania, but the deal it announced on July 2, 2026 looks different from the operating businesses it has spent the past year absorbing. Instead of a network of running dispensaries, Vireo is acquiring a dormant retail permit — and the right to build up to six medical marijuana stores in a state where it does not currently operate.

The Minneapolis-based multistate operator is making the purchase through Vive Penn, a joint venture with Hive Holdings. Vive signed a securities purchase agreement to acquire FarmX, the entity that does business as PhytoNatural and holds the license. The transaction values that license at roughly $20 million and pushes Vireo into its 11th state.

A license, not revenue

What the venture is buying is optionality. PhytoNatural’s permit is non-operational, with no stores and no revenue attached to it today. Subject to Pennsylvania regulatory approval, the permit would let Vive open as many as six dispensaries. That sets the deal apart from Vireo’s other recent moves. Its all-stock agreement to absorb Tampa-based FLUENT brought an existing Florida retail network, and its Colorado and Nevada deals folded in operating storefronts. In Pennsylvania, Vireo is paying for a foothold it still has to build.

The consideration is structured to match that risk. Vive will pay $8 million in cash at closing, with the remaining $12 million coming in about 645,161 Vireo subordinate voting shares — and those shares are not issued until two years after the deal closes. The deferred stock pushes out the dilution and ties the seller to Vireo’s value two years down the line rather than at signing. The relatively small share count reflects Vireo’s 30-for-1 share consolidation, a reverse split that took effect June 5, 2026 as cannabis operators prepare for a possible move onto US stock exchanges — a step Trulieve recently took by listing on the NYSE.

Vireo is not a newcomer to the state. The company sold its Pennsylvania cultivation and dispensary operations to Jushi Holdings in 2020, exiting to focus on core markets before its current management began rebuilding the platform through acquisitions.

The latest stop on a buying run

The Pennsylvania move extends a dealmaking run that began in late 2024, when Vireo agreed to acquire four single-state operators: Deep Roots Harvest in Nevada, The Flowery in Florida, Proper Brands in Missouri and WholesomeCo in Utah. It has since taken a controlling stake in Schwazze, the distressed Colorado and New Mexico operator; paid $49 million for PharmaCann’s Colorado assets and the LivWell brand; and folded in the Eaze delivery business. In recent months it agreed to acquire FLUENT, struck a Nevada deal for C21 Investments, and closed a purchase of equity in Maryland dispensaries.

The pace shows up in the numbers. Vireo reported first-quarter revenue of $106.2 million, up 333.5% from a year earlier and driven almost entirely by closed acquisitions. The company said those deals moved it to the fourth-largest cannabis company by revenue on a pro forma basis, and that it ended the quarter with $137.8 million in cash and expected to stay acquisitive. Vireo now operates about 170 dispensaries across 10 states.

Why Pennsylvania

Pennsylvania is among the larger US medical markets still closed to adult-use sales. CEO John Mazarakis called it “an attractive medical market, approaching approximately 450,000 registered patients in the fifth most populous state in the country,” and pointed to a limited-license structure that caps the number of operators.

That cap is also what gives a dormant permit its value: new licenses are scarce, so acquiring an existing one is often the only way in. The larger question is what the market becomes. State lawmakers have repeatedly failed to legalize adult-use sales, most recently when the state Senate voted down a cannabis control board bill. A conversion to adult-use would sharply widen the customer base for whoever holds retail permits; continued gridlock leaves Vireo building medical-only stores in a state that has resisted broader reform. Other multistate operators have made similar option-style bets on limited-license states.

For now, little of it is settled. The purchase is expected to close two business days after the parties clear all conditions, including the required regulatory approvals, and the six contemplated stores would each need their own sign-offs before opening. Vireo has bought the right to enter Pennsylvania; turning that into operating dispensaries is a separate step.